Anti-PSMA antibodies and uses thereof
US11987641B2 · kind B2 · utility
0Cited by
21References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 25, 2022 |
| Grant date | May 21, 2024 |
| Priority date | — |
| Expiry date | Aug 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are antibodies or antigen binding fragments thereof that bind prostate specific membrane antigen (PSMA), polynucleotides, vectors, host cells, radioconjugates, antibody drug conjugates and methods of treating cancer using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.